| Acetic acid, 2-[1,4-dihydro-7-(phenylmethoxy)cyclopent[b]indol-3(2H)-ylidene]-, ethyl ester |
2-（7-（苄氧基）-1,2-二氢环戊[b]吲哚-3（4H）-亚乙基）乙酸乙酯 |
1318262-62-2 |
| 1-Piperidinecarboxamide, 4-(1,2-dihydro-2-oxo-3-quinolinyl)-N-[(1R)-1-[(7-methyl-1H-indazol-5-yl)methyl]-2-[4-(1-methyl-4-piperidinyl)-1-piperazinyl]-2-oxoethyl]- |
1-Piperidinecarboxamide, 4-(1,2-dihydro-2-oxo-3-quinolinyl)-N-[(1R)-1-[(7-methyl-1H-indazol-5-yl)methyl]-2-[4-(1-methyl-4-piperidinyl)-1-piperazinyl]-2-oxoethyl]- |
1337918-83-8 |
| 4-tert-Butylphenylboronic acid |
4-叔丁基苯硼酸 |
123324-71-0 |
| [6-[benzoyl(methyl)amino]-5-methyl-3-pyridyl]boronic acid |
奥泽沙星中间体D(中九) |
446299-81-6 |
| Etrasimod |
APD334 |
1206123-37-6 |
| (R)-2-AMINOTETRALIN |
(R)-1,2,3,4-四氢-1-萘胺 |
21966-60-9 |
| 3-[1,2,3,6-Tetrahydro-1-(phenylmethyl)-4-pyridinyl]-2(1H)-quinolinone |
3-[1,2,3,6-四氢-1-(苯基甲基)-4-吡啶基]-2(1H)-喹啉酮 |
783368-14-9 |
| L-Phenylalanine, L-leucyl-, methyl ester, monohydrochloride |
L-Phenylalanine, L-leucyl-, methyl ester, monohydrochloride |
6461-07-0 |
| 4,6-Methano-1,3,2-benzodioxaborole-2-MethanaMine,hexahydro-3a,5,5-triMethyl-a-(2-Methylpropyl)-N,N-bis(triMethylsilyl)-,(aR,3aS,4S,6S,7aR)- |
4,6-Methano-1,3,2-benzodioxaborole-2-MethanaMine,hexahydro-3a,5,5-triMethyl-a-(2-Methylpropyl)-N,N-bis(triMethylsilyl)-,(aR,3aS,4S,6S,7aR)- |
514820-48-5 |
| Vazegepant HCl |
Vazegepant HCl |
1414976-20-7 |
| 1146629-80-2 |
1146629-80-2 |
1146629-80-2 |
| (+/-)-8-METHYLDECANAL |
(+/-)-8-METHYLDECANAL |
127793-88-8 |
| ethyl 2-(7-hydroxy-1,2,3,4-tetrahydrocyclopenta[b]indol-3-yl)acetate(WXG02032) |
乙基 2-(7-羟基-1,2,3,4-四氢环戊二烯并[B]吲哚-3-基)醋酸盐 |
1206124-13-1 |
| Sorafenib Impurity 6 |
索拉非尼杂质 6 |
1285533-84-7 |
| benzyl ((S)-2-((tert-butoxycarbonyl)aMino)-4-phenylbutanoyl)-L-leucyl-L-phenylalaninate |
(ALPHAS)-ALPHA-[[叔丁氧羰基]氨基]苯丁酰基-L-亮氨酰基-L-苯丙氨酸苄酯 |
868540-15-2 |
| CarbaMic acid, N-[(1S)-3-Methyl-1-[[(2R)-2-Methyl-2-oxiranyl]carbonyl]butyl]-, 1,1-diMethylethyl ester |
((1S)-3-甲基-1-(((2R)-2-甲基环氧乙基)羰基)丁基)氨基甲酸叔丁酯 |
247068-82-2 |
| Grapiprant |
GRAPIPRANT |
415903-37-6 |
| 3-Aminoisoxazole |
3-氨基异恶唑 |
1750-42-1 |
| 3-Ethoxy-4-Methoxy-alpha-[(Methylsulfonyl)Methyl]-benzeneMethanaMine |
3-乙氧基-4-甲氧基-ALPHA-[(甲基磺酰基)甲基]-苯甲胺 |
253168-94-4 |
| Ozenoxacin intermediate |
Ozenoxacin intermediate |
103877-38-9 |
QQ
微信
